Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells

FEBS Letters

Volumn 589, Issue 20, 2015, Pages 3154-3164

  Shuang, Ting ^a   Wang, Min ^a   Shi, Cong ^a   Zhou, Yingying ^a   Wang, Dandan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance; miR 134 expression; Ovarian cancer; Paclitaxel resistance; Pak2 gene

Indexed keywords

MICRORNA; MICRORNA 134; P21 ACTIVATED KINASE 2; PACLITAXEL; PROTEIN BAD; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN134 MICRORNA, HUMAN; P21 ACTIVATED KINASE; PAK2 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; GENE; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARIAN CANCER CELL LINE; OVARIAN TISSUE; PAK2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; AGED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; NUCLEOTIDE SEQUENCE; OVARIAN NEOPLASMS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; P21-ACTIVATED KINASES; PACLITAXEL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84943198456     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.08.047     Document Type: Article

References (27)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J. Clin. 63 2013 11 30
2. W.P. McGuire 3rd, and M. Markman Primary ovarian cancer chemotherapy: current standards of care Br. J. Cancer 89 Suppl 3 2003 S3 S8
3. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
4. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
5. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
6. M.X. Liu, M.K. Siu, S.S. Liu, J.W. Yam, H.Y. Ngan, and D.W. Chan Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer Oncotarget 5 2014 944 958
7. X. Fu, J. Tian, L. Zhang, Y. Chen, and Q. Hao Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells FEBS Lett. 586 2012 1279 1286
8. F. Dai, Y. Zhang, and Y. Chen Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma Hum. Pathol. 45 2014 1285 1293
9. J.K. Chan, K. Blansit, T. Kiet, A. Sherman, G. Wong, C. Earle, and L.Y. Bourguignon The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer Gynecol. Oncol. 132 2014 739 744
10. D. Zou, D. Wang, R. Li, Y. Tang, L. Yuan, X. Long, and Q. Zhou MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK Tumour Biol. 2015
11. J.H. Huh, T.H. Kim, K. Kim, J.A. Song, Y.J. Jung, J.Y. Jeong, M.J. Lee, Y.K. Kim, D.H. Lee, and H.J. An Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer Br. J. Cancer 109 2013 452 461
12. D.M. Cittelly, and et al. Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel Mol. Cancer Ther. 11 2012 2556 2565
13. L. Guo, Y. Liu, Y. Bai, Y. Sun, F. Xiao, and Y. Guo Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis Eur. J. Cancer 46 2010 1692 1702
14. R. Hamano, H. Miyata, M. Yamasaki, Y. Kurokawa, J. Hara, J.H. Moon, K. Nakajima, S. Takiguchi, Y. Fujiwara, M. Mori, and Y. Doki Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway Clin. Cancer Res. 17 2011 3029 3038
15. T. Hirota, Y. Date, Y. Nishibatake, H. Takane, Y. Fukuoka, Y. Taniguchi, N. Burioka, E. Shimizu, H. Nakamura, K. Otsubo, and I. Ieiri Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues Lung Cancer 77 2012 16 23
16. K. Kitamura, M. Seike, T. Okano, K. Matsuda, A. Miyanaga, H. Mizutani, R. Noro, Y. Minegishi, K. Kubota, and A. Gemma MiR-134/487b/655 cluster regulates TGF-beta-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells Mol. Cancer Ther. 13 2014 444 453
17. Y. Huang, Y. Qi, Q. Ruan, Y. Ma, R. He, Y. Ji, and Z. Sun A rapid method to screen putative mRNA targets of any known microRNA Virol. J. 8 2011 8
18. A. Schurmann, A.F. Mooney, L.C. Sanders, M.A. Sells, H.G. Wang, J.C. Reed, and G.M. Bokoch P21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis Mol. Cell. Biol. 20 2000 453 461
19. R. Jakobi, E. Moertl, and M.A. Koeppel P21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts J. Biol. Chem. 276 2001 16624 16634
20. B. Stordal, N. Pavlakis, and R. Davey A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship Cancer Treat. Rev. 33 2007 688 703
21. A.M. Duursma, M. Kedde, M. Schrier, C. le Sage, and R. Agami MiR-148 targets human DNMT3b protein coding region RNA 14 2008 872 877
22. J.J. Forman, A. Legesse-Miller, and H.A. Coller A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence Proc. Natl. Acad. Sci. U.S.A. 105 2008 14879 14884
23. Y. Tay, J. Zhang, A.M. Thomson, B. Lim, and I. Rigoutsos MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation Nature 455 2008 1124 1128
24. P.R. Molli, D.Q. Li, B.W. Murray, S.K. Rayala, and R. Kumar PAK signaling in oncogenesis Oncogene 28 2009 2545 2555
25. M. Radu, G. Semenova, R. Kosoff, and J. Chernoff PAK signalling during the development and progression of cancer Nat. Rev. Cancer 14 2014 13 25
26. R. Jakobi, C.C. McCarthy, M.A. Koeppel, and D.K. Stringer Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation J. Biol. Chem. 278 2003 38675 38685
27. X. Li, W. Wen, K. Liu, F. Zhu, M. Malakhova, C. Peng, T. Li, H.G. Kim, W. Ma, Y.Y. Cho, A.M. Bode, Z. Dong, and Z. Dong Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines J. Biol. Chem. 286 2011 22291 22299